Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): The Protocol for a Copenhagen IBD Inception Cohort Study

Research output: Contribution to journalJournal articlepeer-review

  1. Inhaled anti-asthma therapies following hormone therapy in women: a nationwide cohort study

    Research output: Contribution to journalJournal articlepeer-review

  2. Mucosal cryobiopsies: a new method for studying airway pathology in asthma

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

INTRODUCTION: Inflammatory bowel diseases (IBD), encompassing Crohn's disease and ulcerative colitis, are chronic, inflammatory diseases of the gastrointestinal tract. We have initiated a Danish population-based inception cohort study aiming to investigate the underlying mechanisms for the heterogeneous course of IBD, including need for, and response to, treatment.

METHODS AND ANALYSIS: IBD Prognosis Study is a prospective, population-based inception cohort study of unselected, newly diagnosed adult, adolescent and paediatric patients with IBD within the uptake area of Hvidovre University Hospital and Herlev University Hospital, Denmark, which covers approximately 1 050 000 inhabitants (~20% of the Danish population). The diagnosis of IBD will be according to the Porto diagnostic criteria in paediatric and adolescent patients or the Copenhagen diagnostic criteria in adult patients. All patients will be followed prospectively with regular clinical examinations including ileocolonoscopies, MRI of the small intestine, validated patient-reported measures and objective examinations with intestinal ultrasound. In addition, intestinal biopsies from ileocolonoscopies, stool, rectal swabs, saliva samples, swabs of the oral cavity and blood samples will be collected systematically for the analysis of biomarkers, microbiome and genetic profiles. Environmental factors and quality of life will be assessed using questionnaires and, when available, automatic registration of purchase data. The occurrence and course of extraintestinal manifestations will be evaluated by rheumatologists, dermatologists and dentists, and assessed by MR cholangiopancreatography, MR of the spine and sacroiliac joints, ultrasonography of peripheral joints and entheses, clinical oral examination, as well as panoramic radiograph of the jaws. Fibroscans and dual-energy X-ray absorptiometry scans will be performed to monitor occurrence and course of chronic liver diseases, osteopenia and osteoporosis.

ETHICS AND DISSEMINATION: This study has been approved by Ethics Committee of the Capital Region of Denmark (approval number: H-20065831). Study results will be disseminated through publication in international scientific journals and presentation at (inter)national conferences.

Original languageEnglish
Article numbere055779
JournalBMJ Open
Volume12
Issue number6
Number of pages12
ISSN2044-6055
DOIs
Publication statusPublished - 27 Jun 2022

    Research areas

  • Adult gastroenterology, EPIDEMIOLOGY, IMMUNOLOGY, Inflammatory bowel disease, MOLECULAR BIOLOGY, Paediatric gastroenterology, Inflammatory Bowel Diseases/diagnosis, Prognosis, Prospective Studies, Humans, Colitis, Ulcerative/therapy, Microbiota, Adolescent, Quality of Life, Adult, Child, Cohort Studies

ID: 78439580